ARCHIVES

New Immunotherapy Increased Survival Of Neuroblastoma In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 33 No. 9 | September 24, 2010

Download PDF Visit The Full Archive

Related Articles

A Biostatistics Paper Alleges Potential Harm To Patients In Two Duke Clinical Studies

October 2, 2009

Community Hospital Oncology Program RFP Deadline Moved Back to Sept. 5

June 22, 1979

Congressional Report Says NCI Ignored Das, Procedure, In Charges To Screening Guidelines

November 4, 1994

Cephalon To Plead Guilty, Pay $425M For Off-Label Marketing.

October 3, 2008

New Predictive Score May Help In Planning Adjuvant Therapy

September 26, 2008

In Brief: Russos of Michigan Move To Fox Chase; Becker Named To Endowed Chair; NCI’s David Byar Dies

August 23, 1991